COVID-19: NIAID CLINICAL SITE MONITORING

COVID-19：NIAID 临床现场监测

• 批准号: 10687948
• 负责人: KIMBERLY SMITH
• 金额: $ 91.26万
• 依托单位: PPD DEVELOPMENT LP
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-01 至 2023-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10687948
• 关键词: COVID-19; Clinical Research; Clinical Trials; Contracts; Monitor; Monitoring Clinical Trials; Monoclonal Antibodies; National Institute of Allergy and Infectious Disease; Outpatients; Research; Research Project Grants; Services; clinical research site; public health emergency; response

The purpose of the Clinical Site Monitoring contract is to provide comprehensive clinical site and study monitoring services for the NIAID clinical trial research portfolio, including the delivery of monitoring services for unanticipated NIAID clinical research projects that may be required in response to emerging needs or public health emergencies. This project will provide clinical trial monitoring services for the COVID-19 clinical trial ACTIV-2 (Outpatient Monoclonal Antibodies And Other Therapies).

临床现场监测合同的目的是为NIAID临床试验研究组合提供全面的临床现场和研究监测服务，包括为NIAID临床研究项目提供监测服务，这些项目可能需要应对新出现的需求或公共卫生紧急情况。该项目将为新冠肺炎临床试验ACTV-2(门诊单抗等疗法)提供临床试验监测服务。